dexmedetomidine has been researched along with Acute Edematous Pancreatitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, CQ; Huang, DY; Li, Q; Miao, Y; Shen, HB; Shi, CY | 1 |
| Gao, L; Li, B; Li, G; Li, W; Li, Y; Lu, G; Pan, Y; Tong, Z; Xie, X; Zhang, J | 1 |
2 other study(ies) available for dexmedetomidine and Acute Edematous Pancreatitis
| Article | Year |
|---|---|
Dexmedetomidine attenuates inflammation and pancreatic injury in a rat model of experimental severe acute pancreatitis via cholinergic anti-inflammatory pathway.
Topics: Acute Disease; Animals; Dexmedetomidine; Inflammation; Neuroimmunomodulation; Pancreatitis; Rats; Tumor Necrosis Factor-alpha | 2020 |
Dexmedetomidine attenuates pancreatic injury and inflammatory response in mice with pancreatitis by possible reduction of NLRP3 activation and up-regulation of NET expression.
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Dexmedetomidine; Dose-Response Relationship, Drug; Immunologic Factors; Male; Mice; Mice, Inbred ICR; NLR Family, Pyrin Domain-Containing 3 Protein; Norepinephrine Plasma Membrane Transport Proteins; Pancreatitis; Treatment Outcome; Up-Regulation | 2018 |